Trying to conceive can become emotionally and physically challenging, especially for women who do not respond well to standard IVF stimulation protocols. In some fertility cases, specialists may recommend additional hormone support to help improve follicle development and egg quality during treatment.
One medication that has been used in fertility care for many years is Omnitrope, a synthetic human growth hormone commonly included in certain IVF protocols. Omnitrope® is often prescribed for women considered “poor responders,” women over 38, or patients who may need additional support during ovarian stimulation. Fertility specialists may use this medication to help support follicle maturation, estrogen production, and overall oocyte quality during assisted reproductive treatment cycles.
What Is Omnitrope®?
Omnitrope is the brand name for somatropin, a synthetic form of human growth hormone (GH). While the medication is widely known for treating growth hormone deficiency and certain growth-related conditions, fertility specialists also use it in some IVF treatment protocols to support ovarian response and egg development.
In fertility care, Omnitrope® is mainly used for women who may have low natural growth hormone levels or who have previously responded poorly to traditional IVF stimulation medications. The medication is intended to support follicle development and improve the environment surrounding developing eggs.
When Is Omnitrope® Used?
Omnitrope® is commonly used during fertility treatment for women who may benefit from additional hormonal support during ovarian stimulation. Fertility specialists often prescribe it for:
- Women with poor ovarian reserve
- Women over age 38
- Patients classified as “poor responders” during IVF
- Women requiring higher gonadotropin doses
- Certain IVF stimulation protocols
The medication may help support aromatase activity, which plays an important role in converting testosterone into estrogen inside the body. Increased estrogen support may help encourage follicle development and ovulation during fertility treatment.
Some fertility specialists also believe that normal growth hormone levels inside ovarian follicles may support healthier egg development and improved oocyte quality.
Dosage And Administration
Omnitrope® is available in pre-filled cartridges or injectable vials and is administered as a subcutaneous injection. The medication may be injected using an injector pen depending on the formulation prescribed.
Dosages can vary significantly depending on the patient’s age, hormone levels, fertility diagnosis, ovarian reserve, and IVF treatment plan. Because fertility protocols are highly individualized, patients should always follow the instructions provided by their reproductive endocrinologist carefully.
The medication is usually included as part of a broader IVF medication protocol alongside gonadotropins and other fertility hormones.
Special Precautions
Omnitrope may not be appropriate for all patients. Women with certain medical conditions should discuss risks carefully with their fertility specialist before starting treatment.
The medication should generally be avoided in patients with:
- Active cancer or tumors
- Allergies to growth hormone medications
- Diabetes-related eye disease
- Sleep apnea
- Certain serious illnesses or surgical complications
- Severe breathing problems
Omnitrope® is also not typically recommended for women who are already pregnant or breastfeeding.
Possible Side Effects
Like many hormone-based fertility medications, Omnitrope® may cause side effects in some individuals. Reactions can range from mild to more serious depending on the patient and treatment response.
Common Side Effects
- Headache
- Fluid retention (edema)
- Injection site redness or swelling
- Muscle or joint pain
- Tingling or numbness in extremities
- Elevated blood sugar levels
- Hypothyroidism
Serious Side Effects
Less common but potentially serious side effects may include:
- Vision changes
- Increased pressure in the brain
- Pancreatitis
- Nausea or vomiting
- Return of tumor growth in certain patients
Patients should contact their healthcare provider immediately if severe symptoms occur.
Proper Storage And Disposal
Omnitrope® should be stored in its original packaging inside a refrigerator between 36°F and 46°F. The medication should never be frozen.
Used cartridges are typically discarded 28 days after first use, depending on the specific product instructions. Patients should safely dispose of needles, syringes, and unused medication according to healthcare provider recommendations.
Important Safety Information
Omnitrope® is a prescription medication that should only be used under the supervision of a licensed fertility specialist or healthcare professional. Fertility treatment protocols vary significantly between patients, and proper monitoring is important throughout the treatment process.
Patients should discuss all risks, benefits, side effects, and treatment expectations with their fertility provider before beginning therapy.